BIG PHARMA UP TO NO GOOD ONCE AGAIN..................selling drugs made of coconut oil at killer prices.
Alzheimer’s afflicts 5.2 million people in the US and is the 7th leading cause of death. The cost of treating it is estimated at $148 billion.
Mary Newport, medical director of the neonatal intensive care unit at Spring Hill Regional Hospital in Florida, her husband Steve, was diagnosed with Alzheimer’s Disease.
They started him on Alzheimer’s drugs—Aricept, Namenda, Exelon—but his disease worsened steadily.
She discovered that with Alzheimer’s disease, certain brain cells may have difficulty utilizing glucose (made from the carbohydrates we eat), the brain’s principal source of energy. Without fuel, these precious neurons may begin to die. There is an alternative energy source for brain cells—fats known as ketones.
Another way to produce ketones is by consuming oils that have medium-chain triglycerides. When MCT oil is digested, the liver converts it into ketones.
Dr. Newport learned that the ingredient in the new drug trial which was showing so much promise was simply MCT oil derived from coconut oil or palm kernel oil, and that a dose of 20 grams (about 20 ml or 4 teaspoons) was used to produce these results.
Mr. Newport, not being able to get into the drug trial, started taking the coconut oil twice a day. At this point, he could barely remember how to draw a clock.
Over the next year, the dementia reversed itself: his reading comprehension has improved dramatically, and his short-term memory is improving—he often brings up events that happened days to weeks earlier and relays telephone conversations with accurate detail. A recent MRI shows that the brain atrophy has been completely halted.